Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Aug 1;98(3):731–740. doi: 10.1172/JCI118845

Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.

R D Schrier 1, C A Wiley 1, C Spina 1, J A McCutchan 1, I Grant 1
PMCID: PMC507483  PMID: 8698865

Abstract

To investigate the association of antigen specific CD4 T cell activation with HIV disease progression and AIDS-related central nervous system damage, T cell proliferation responses to HIV, CMV, and HSV were evaluated in infected individuals. CD4 T cell loss and neurocognitive impairment were assessed at 6-mo intervals. Individuals with known times of seroconversion who responded to more HIV peptides were at greater risk of progressing to < 200 CD4 T cells (P = 0.04) and dying (P = 0.03) than those with responses to fewer peptides. A positive correlation (0.52) was seen between the breadth of the HIV proliferation response and HIV plasma RNA levels. Higher proliferation responses to CMV and HSV were also associated with more rapid CD4 loss (P = 0.05). HLA phenotyped individuals (n = 150) with two HLA-DR alleles associated with response to more HIV peptides and CMV (DR-2,5,w6,10) were less likely to develop neurocognitive (P = 0.002) and neurologic impairment (P = 0.04), but were not protected from CD4 loss and death. Thus, the ability to generate a greater T cell proliferation response to HIV and opportunistic herpes viruses may lead to resistance to central nervous system damage, but also risk of more rapid HIV disease progression.

Full Text

The Full Text of this article is available as a PDF (184.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed A. R., Strom H., Bierman S., Myers-Elliot R., Tiwari P., Terasaki P. I. A study of HLA and DRw antigens in severe recurrent herpes progenitalis (HSV-2) infection. J Am Acad Dermatol. 1982 May;6(5):898–901. doi: 10.1016/s0190-9622(82)70079-9. [DOI] [PubMed] [Google Scholar]
  2. Almarri A., Batchelor J. R. HLA and hepatitis B infection. Lancet. 1994 Oct 29;344(8931):1194–1195. doi: 10.1016/s0140-6736(94)90510-x. [DOI] [PubMed] [Google Scholar]
  3. Babbitt B. P., Allen P. M., Matsueda G., Haber E., Unanue E. R. Binding of immunogenic peptides to Ia histocompatibility molecules. 1985 Sep 26-Oct 2Nature. 317(6035):359–361. doi: 10.1038/317359a0. [DOI] [PubMed] [Google Scholar]
  4. Bastin J., Rothbard J., Davey J., Jones I., Townsend A. Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. J Exp Med. 1987 Jun 1;165(6):1508–1523. doi: 10.1084/jem.165.6.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bentin J., Tsoukas C. D., McCutchan J. A., Spector S. A., Richman D. D., Vaughan J. H. Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus. J Clin Immunol. 1989 Mar;9(2):159–168. doi: 10.1007/BF00916944. [DOI] [PubMed] [Google Scholar]
  6. Biddison W. E. The role of the human major histocompatibility complex in cytotoxic T-cell responses to virus-infected cells. J Clin Immunol. 1982 Jan;2(1):1–9. doi: 10.1007/BF00915971. [DOI] [PubMed] [Google Scholar]
  7. Blancho G., Josien R., Douillard D., Bignon J. D., Cesbron A., Soulillou J. P. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease. Transplantation. 1992 Nov;54(5):871–874. doi: 10.1097/00007890-199211000-00020. [DOI] [PubMed] [Google Scholar]
  8. Blatt S. P., Hendrix C. W., Butzin C. A., Freeman T. M., Ward W. W., Hensley R. E., Melcher G. P., Donovan D. J., Boswell R. N. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med. 1993 Aug 1;119(3):177–184. doi: 10.7326/0003-4819-119-3-199308010-00001. [DOI] [PubMed] [Google Scholar]
  9. Boccellari A. A., Dilley J. W., Chambers D. B., Yingling C. D., Tauber M. A., Moss A. R., Osmond D. H. Immune function and neuropsychological performance in HIV-1-infected homosexual men. J Acquir Immune Defic Syndr. 1993 Jun;6(6):592–601. [PubMed] [Google Scholar]
  10. Buus S., Sette A., Colon S. M., Miles C., Grey H. M. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science. 1987 Mar 13;235(4794):1353–1358. doi: 10.1126/science.2435001. [DOI] [PubMed] [Google Scholar]
  11. Bylsma S. S., Achim C. L., Wiley C. A., Gonzalez C., Kuppermann B. D., Berry C., Freeman W. R. The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Arch Ophthalmol. 1995 Jan;113(1):89–95. doi: 10.1001/archopht.1995.01100010091026. [DOI] [PubMed] [Google Scholar]
  12. Chicz R. M., Urban R. G., Gorga J. C., Vignali D. A., Lane W. S., Strominger J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med. 1993 Jul 1;178(1):27–47. doi: 10.1084/jem.178.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Converse P. J., Fehniger T. E., Ehrnst A., Strannegård O., Britton S. Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals. Clin Exp Immunol. 1990 Dec;82(3):559–566. doi: 10.1111/j.1365-2249.1990.tb05490.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Daar E. S., Moudgil T., Meyer R. D., Ho D. D. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991 Apr 4;324(14):961–964. doi: 10.1056/NEJM199104043241405. [DOI] [PubMed] [Google Scholar]
  15. DeLisi C., Berzofsky J. A. T-cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci U S A. 1985 Oct;82(20):7048–7052. doi: 10.1073/pnas.82.20.7048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Epstein J. S., Frederick W. R., Rook A. H., Jackson L., Manischewitz J. F., Mayner R. E., Masur H., Enterline J. C., Djeu J. Y., Quinnan G. V., Jr Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis. 1985 Oct;152(4):727–733. doi: 10.1093/infdis/152.4.727. [DOI] [PubMed] [Google Scholar]
  17. Fox B. S., Carbone F. R., Germain R. N., Paterson Y., Schwartz R. H. Processing of a minimal antigenic peptide alters its interaction with MHC molecules. Nature. 1988 Feb 11;331(6156):538–540. doi: 10.1038/331538a0. [DOI] [PubMed] [Google Scholar]
  18. Gendelman H. E., Phelps W., Feigenbaum L., Ostrove J. M., Adachi A., Howley P. M., Khoury G., Ginsberg H. S., Martin M. A. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9759–9763. doi: 10.1073/pnas.83.24.9759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gnann J. W., Jr, Schwimmbeck P. L., Nelson J. A., Truax A. B., Oldstone M. B. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J Infect Dis. 1987 Aug;156(2):261–267. doi: 10.1093/infdis/156.2.261. [DOI] [PubMed] [Google Scholar]
  20. Goudsmit J., de Wolf F., Paul D. A., Epstein L. G., Lange J. M., Krone W. J., Speelman H., Wolters E. C., Van der Noordaa J., Oleske J. M. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet. 1986 Jul 26;2(8500):177–180. doi: 10.1016/s0140-6736(86)92485-2. [DOI] [PubMed] [Google Scholar]
  21. Grant I., Heaton R. K. Human immunodeficiency virus-type 1 (HIV-1) and the brain. J Consult Clin Psychol. 1990 Feb;58(1):22–30. doi: 10.1037//0022-006x.58.1.22. [DOI] [PubMed] [Google Scholar]
  22. Heaton R. K., Grant I., Anthony W. Z., Lehman R. A. A comparison of clinical and automated interpretation of the Halstead-Reitan Battery. J Clin Neuropsychol. 1981 Jul;3(2):121–141. doi: 10.1080/01688638108403118. [DOI] [PubMed] [Google Scholar]
  23. Heaton R. K., Grant I., Butters N., White D. A., Kirson D., Atkinson J. H., McCutchan J. A., Taylor M. J., Kelly M. D., Ellis R. J. The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995 May;1(3):231–251. doi: 10.1017/s1355617700000230. [DOI] [PubMed] [Google Scholar]
  24. Hill A. V., Allsopp C. E., Kwiatkowski D., Anstey N. M., Twumasi P., Rowe P. A., Bennett S., Brewster D., McMichael A. J., Greenwood B. M. Common west African HLA antigens are associated with protection from severe malaria. Nature. 1991 Aug 15;352(6336):595–600. doi: 10.1038/352595a0. [DOI] [PubMed] [Google Scholar]
  25. Hill A. V., Elvin J., Willis A. C., Aidoo M., Allsopp C. E., Gotch F. M., Gao X. M., Takiguchi M., Greenwood B. M., Townsend A. R. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 1992 Dec 3;360(6403):434–439. doi: 10.1038/360434a0. [DOI] [PubMed] [Google Scholar]
  26. Ho D. D., Rota T. R., Schooley R. T., Kaplan J. C., Allan J. D., Groopman J. E., Resnick L., Felsenstein D., Andrews C. A., Hirsch M. S. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985 Dec 12;313(24):1493–1497. doi: 10.1056/NEJM198512123132401. [DOI] [PubMed] [Google Scholar]
  27. Hom R. C., Finberg R. W., Mullaney S., Ruprecht R. M. Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells. J Virol. 1991 Jan;65(1):220–224. doi: 10.1128/jvi.65.1.220-224.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jabs D. A., Green W. R., Fox R., Polk B. F., Bartlett J. G. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989 Jul;96(7):1092–1099. doi: 10.1016/s0161-6420(89)32794-1. [DOI] [PubMed] [Google Scholar]
  29. Jones E. H., Biggar R. J., Nkrumah F. K., Lawler S. D. Study of the HLA system in Burkitt's lymphoma. Hum Immunol. 1980 Oct;1(3):207–210. doi: 10.1016/0198-8859(80)90015-4. [DOI] [PubMed] [Google Scholar]
  30. Kaslow R. A., Carrington M., Apple R., Park L., Muñoz A., Saah A. J., Goedert J. J., Winkler C., O'Brien S. J., Rinaldo C. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med. 1996 Apr;2(4):405–411. doi: 10.1038/nm0496-405. [DOI] [PubMed] [Google Scholar]
  31. Klatzmann D., Barré-Sinoussi F., Nugeyre M. T., Danquet C., Vilmer E., Griscelli C., Brun-Veziret F., Rouzioux C., Gluckman J. C., Chermann J. C. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science. 1984 Jul 6;225(4657):59–63. doi: 10.1126/science.6328660. [DOI] [PubMed] [Google Scholar]
  32. Kraat Y. J., Christiaans M. H., Nieman F. H., van den Berg-Loonen P. M., van Hooff J. P., Bruggeman C. A. Increased frequency of CMV infection in HLA-DR7 matched renal allograft recipients. Lancet. 1993 Feb 20;341(8843):494–495. doi: 10.1016/0140-6736(93)90248-f. [DOI] [PubMed] [Google Scholar]
  33. Levy R. M., Bredesen D. E., Rosenblum M. L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985 Apr;62(4):475–495. doi: 10.3171/jns.1985.62.4.0475. [DOI] [PubMed] [Google Scholar]
  34. Louie L. G., Newman B., King M. C. Influence of host genotype on progression to AIDS among HIV-infected men. J Acquir Immune Defic Syndr. 1991;4(8):814–818. [PubMed] [Google Scholar]
  35. Lucey D. R., McGuire S. A., Clerici M., Hall K., Benton J., Butzin C. A., Ward W. W., Shearer G., Boswell R. N., Hendrix C. W. Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1. J Infect Dis. 1991 May;163(5):971–975. doi: 10.1093/infdis/163.5.971. [DOI] [PubMed] [Google Scholar]
  36. Mackewicz C. E., Ortega H. W., Levy J. A. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest. 1991 Apr;87(4):1462–1466. doi: 10.1172/JCI115153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mann D. L., Murray C., Yarchoan R., Blattner W. A., Goedert J. J. HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS. J Acquir Immune Defic Syndr. 1988;1(1):13–17. [PubMed] [Google Scholar]
  38. Mehta P., Gulevich S. J., Thal L. J., Jin H., Olichney J. M., McCutchan J. A., Heaton R. K., Kirson D., Kaplanski G., Nelson J. Neurological Symptoms, Not Signs,<br />Are Common in Early HIV Infection. J NeuroAIDS. 1996;1(2):67–85. doi: 10.1300/J128v01n02_05. [DOI] [PubMed] [Google Scholar]
  39. Mellors J. W., Kingsley L. A., Rinaldo C. R., Jr, Todd J. A., Hoo B. S., Kokka R. P., Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 1995 Apr 15;122(8):573–579. doi: 10.7326/0003-4819-122-8-199504150-00003. [DOI] [PubMed] [Google Scholar]
  40. Mosca J. D., Bednarik D. P., Raj N. B., Rosen C. A., Sodroski J. G., Haseltine W. A., Pitha P. M. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature. 1987 Jan 1;325(6099):67–70. doi: 10.1038/325067a0. [DOI] [PubMed] [Google Scholar]
  41. O'Brien W. A., Grovit-Ferbas K., Namazi A., Ovcak-Derzic S., Wang H. J., Park J., Yeramian C., Mao S. H., Zack J. A. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood. 1995 Aug 1;86(3):1082–1089. [PubMed] [Google Scholar]
  42. Phair J., Jacobson L., Detels R., Rinaldo C., Saah A., Schrager L., Muñoz A. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1992;5(5):490–496. [PubMed] [Google Scholar]
  43. Saha K., Wong P. K. Protective role of cytotoxic lymphocytes against murine leukemia virus-induced neurologic disease and immunodeficiency is enhanced by the presence of helper T cells. Virology. 1992 Jun;188(2):921–925. doi: 10.1016/0042-6822(92)90554-3. [DOI] [PubMed] [Google Scholar]
  44. Saksela K., Stevens C., Rubinstein P., Baltimore D. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1104–1108. doi: 10.1073/pnas.91.3.1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Schrier R. D., Freeman W. R., Wiley C. A., McCutchan J. A. CMV-specific immune responses and HLA phenotypes of AIDS patients who develop CMV retinitis. HNRC Group. HIV Neurobehavioral Research Center. Adv Neuroimmunol. 1994;4(3):327–336. doi: 10.1016/s0960-5428(06)80273-1. [DOI] [PubMed] [Google Scholar]
  46. Schrier R. D., Freeman W. R., Wiley C. A., McCutchan J. A. Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group. J Clin Invest. 1995 Apr;95(4):1741–1746. doi: 10.1172/JCI117851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Schrier R. D., Gnann J. W., Jr, Landes R., Lockshin C., Richman D., McCutchan A., Kennedy C., Oldstone M. B., Nelson J. A. T cell recognition of HIV synthetic peptides in a natural infection. J Immunol. 1989 Feb 15;142(4):1166–1176. [PubMed] [Google Scholar]
  48. Schrier R. D., McCutchan J. A., Venable J. C., Nelson J. A., Wiley C. A. T-cell-induced expression of human immunodeficiency virus in macrophages. J Virol. 1990 Jul;64(7):3280–3288. doi: 10.1128/jvi.64.7.3280-3288.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sheppard H. W., Ascher M. S., McRae B., Anderson R. E., Lang W., Allain J. P. The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J Acquir Immune Defic Syndr. 1991;4(7):704–712. [PubMed] [Google Scholar]
  50. Sheppard H. W., Lang W., Ascher M. S., Vittinghoff E., Winkelstein W. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS. 1993 Sep;7(9):1159–1166. [PubMed] [Google Scholar]
  51. Skolnik P. R., Kosloff B. R., Hirsch M. S. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis. 1988 Mar;157(3):508–514. doi: 10.1093/infdis/157.3.508. [DOI] [PubMed] [Google Scholar]
  52. Staprans S. I., Hamilton B. L., Follansbee S. E., Elbeik T., Barbosa P., Grant R. M., Feinberg M. B. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med. 1995 Dec 1;182(6):1727–1737. doi: 10.1084/jem.182.6.1727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Trauger R. J., Giermakowska W. K., Ferre F., Duffy P. C., Wallace M. R., Lewis D. E., Beecham H. J., Burnett K. G., Jensen F. C., Carlo D. J. Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burden. Immunology. 1993 Apr;78(4):611–615. [PMC free article] [PubMed] [Google Scholar]
  54. Wahren B., Morfeldt-Månsson L., Biberfeld G., Moberg L., Sönnerborg A., Ljungman P., Werner A., Kurth R., Gallo R., Bolognesi D. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol. 1987 Jun;61(6):2017–2023. doi: 10.1128/jvi.61.6.2017-2023.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Walker B. D., Chakrabarti S., Moss B., Paradis T. J., Flynn T., Durno A. G., Blumberg R. S., Kaplan J. C., Hirsch M. S., Schooley R. T. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 1987 Jul 23;328(6128):345–348. doi: 10.1038/328345a0. [DOI] [PubMed] [Google Scholar]
  56. Wang A. M., Doyle M. V., Mark D. F. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9717–9721. doi: 10.1073/pnas.86.24.9717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Webster A., Lee C. A., Cook D. G., Grundy J. E., Emery V. C., Kernoff P. B., Griffiths P. D. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet. 1989 Jul 8;2(8654):63–66. doi: 10.1016/s0140-6736(89)90312-7. [DOI] [PubMed] [Google Scholar]
  58. Wiley C. A., Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol. 1994 Oct;36(4):673–676. doi: 10.1002/ana.410360422. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES